Status:
COMPLETED
Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos
Lead Sponsor:
Sansum Diabetes Research Institute
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Type2 Diabetes Mellitus
Cardiovascular Diseases
Eligibility:
All Genders
7+ years
Brief Summary
The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determina...
Detailed Description
The vision of Mil Familias is to reduce the burden of cardio-metabolic disease among Latino families in Santa Barbara County and beyond. The aim is to establish an observational cohort of 1,000 Latino...
Eligibility Criteria
Inclusion
- Males or females ≥ 7 years of age at enrollment.
- Self-reported Latino heritage.
- Co-resides with immediate family member (as defined above) OR self with established diagnosis of Type 2 Diabetes for at least one year prior to enrollment date.
- Signed and dated written informed consent by the date of enrollment.
- Based on the research staff's judgment, subject or subject's representative must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.
- \-
Exclusion
- Life expectancy \< 6 months.
- Any active clinically significant physical or mental disease or disorder, which in the investigator's opinion could interfere with the participation of the trial.
- Language barriers precluding comprehension of study activities and informed consent.
- Participation in other trials involving medication or device within 1 month prior to enrollment.
- Known or suspected abuse of alcohol, narcotics, or illicit drugs. -
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2022
Estimated Enrollment :
405 Patients enrolled
Trial Details
Trial ID
NCT03830840
Start Date
February 1 2019
End Date
March 29 2022
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sansum Diabetes Research Institute
Santa Barbara, California, United States, 93105